FLT3 and cardiac hypertrophy: The most significantly affected signaling pathways were EIF-2, IL-2, integrin, NGF, VEGF, estrogen receptor, IL-7, FLT3, FGF, oxytocin, cardiac hypertrophy, role of NFAT in cardiac hypertrophy, and neutrophil extracellular trap pathways.